Glenmark Pharma Swings to Profit in Q4 FY25, Declares ₹2.5 Final Dividend
Glenmark Pharmaceuticals Ltd has reported a strong financial turnaround in the fourth quarter (Q4) of FY25, posting a net profit of ₹4.7 crore, compared to a loss of ₹1,218 crore in the same period last year. The company’s consolidated revenue for the quarter rose 6.3% YoY to ₹3,256 crore, driven by growth in India and…
